Efficiency of periodontal therapy for management of CVS diseases in patient with chronic periodontitis: An original research

Fozia Sultana; Ashank Mishra; M. Mahesh Kumar; Annavarapu Sahithi; Kommuri Kavya Reddy; Yella Ramya

doi:10.53730/ijhs.v6nS3.7679

Authors

Fozia Sultana
fozia.freedom@gmail.com
Senior lecturer, Department of periodontics and Implantology, Himachal institute of dental sciences, Paonta sahib, H.P.
Ashank Mishra Assistant Professor, Dept of Periodontics and Implantology, Government Dental College and Hospital, Hyderabad
M. Mahesh Kumar MDS, Periodontist, United Dental Care, Hyderabad, Telangana
Annavarapu Sahithi Consultant Periodontist, Chief Faculty, Zeus Terra Dental Accademy
Kommuri Kavya Reddy Consultant Periodontics and Oral Implantology, Hyderabad, Telangana
Yella Ramya Senior lecturer, Department of Periodontics and Oral Implantology, Care Dental College, Guntur, AP

Keywords:

periodontal disease, cardiovascular diseases, dental prophylaxis, dental scaling

Abstract

To evaluate the effectiveness of periodontal prophylaxis/ treatment in patients with chronic periodontitis already suffering from cardiovascular system (CVS) diseases. 500 Subjects with periodontal diseases (PD) were grouped according to treatment (dental prophylaxis, intensive treatment, and PD without treatment). The Incidence Rates (IRs) of CVS diseases during the 1-year follow-up period were compared among groups. Cox regression analysis adjusted for age, sex, socioeconomic status, residential urbanicity, and comorbidities was used to evaluate the effect of PD treatment on the incidence of CVS diseases. The IR of CVS diseases among subjects without PD was 0.19%/year. Among those with PD, the IR of CVS diseases was lowest in the dental prophylaxis group (0.11%/year), followed by the intensive treatment (0.28%/year) and PD without treatment (0.31%/year; P<0.001) groups. Cox regression showed that the hazard ratio (HR) for CVS diseases was significantly lower in the dental prophylaxis group. PD is associated with a higher risk of CVS diseases, which can be reduced by dental prophylaxis to maintain periodontal health.

Downloads

Download data is not yet available.

References

A. Bascones-Mart´ınez, M. Mu˜noz-Corcuera, S. Noronha, P. Mota, C. Bascones-Ilundain, and J. Campo-Trapero, “Host defence mechanisms against bacterial aggression in periodontal disease: basic mechanisms,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 14, no. 12, pp. e680–e685, 2009.

L. Zhang, B. S. Henson, P.M. Camargo, and D. T. Wong, “The clinical value of salivary biomarkers for periodontal disease,” Periodontology 2000, vol. 51, no. 1, pp. 25–37, 2009.

J. M. Albandar, “Epidemiology and risk factors of periodontal diseases,” Dental Clinics of North America, vol. 49,no. 3, pp. 517– 532, 2005.

D. R. Haynes, “Emerging and future therapies for the treatment of bone loss associated with chronic inflammation,” Inflammo pharmacology, vol. 14, no. 5-6, pp. 193–197, 2006.

J. Khalili, “Periodontal disease: an overview for medical practitioners,” Likars’ka sprava, no. 3-4, pp. 10–21, 2008.

G. C. Armitage, “Development of a classification system for periodontal diseases and conditions,” Annals of Periodontology, vol. 4, no. 1, pp. 1–6, 1999.

D. Baldi, A. Izzotti, P. Bonica, P. Pera, and A. Pulliero, “Degenerative periodontal-diseases and oral osteonecrosis: the role of gene-environment interactions,” Mutation Research— Fundamental and Molecular Mechanisms of Mutagenesis, vol. 667, no. 1-2, pp. 118–131, 2009.

G. C. Armitage and M. P. Cullinan, “Comparison of the clinical features of chronic and aggressive periodontitis,” Periodontology 2000, vol. 53, no. 1, pp. 12–27, 2010.

G. Blandino, I. Milazzo, D. Fazio et al., “Antimicrobial susceptibility and ????-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections,” Journal of Chemotherapy, vol. 19, no. 5, pp. 495–499, 2007.

P. J. Pussinen, S. Paju, P. M¨antyl¨a, and T. Sorsa, “Serum microbial-and host-derived markers of periodontal diseases: a review,” Current Medicinal Chemistry, vol. 14, no. 22, pp. 2402– 2412, 2007.

J. Ruby and J. Barbeau, “The buccale puzzle: the symbiotic nature of endogenous infections of the oral cavity,” Canadian Journal of Infectious Diseases, vol. 13, no. 1, pp. 34–41, 2002.

K. Mattila, M. Vesanen, V. Valtonen et al., “Effect of treating periodontitis on C-reactive protein levels: a pilot study,” BMC Infectious Diseases, vol. 2, article 30, 2002.

D. F. Kinane and G. D. O. Lowe, “How periodontal disease may contribute to cardiovascular disease,” Periodontology 2000, vol. 23, no. 1, pp. 121–126, 2000.

J. Zhu, A. A. Quyyumi, J. E. Norman et al., “Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels,” American Journal of Cardiology, vol. 85,no. 2, pp. 140–146, 2000.

Y. Nakamura, O. Tagusari, Y. Seike et al., “Prevalence of periodontitis and optimal timing of dental treatment in patients undergoing heart valve surgery,” Interactive Cardiovascular and Thoracic Surgery, vol. 12, no. 5, pp. 696–700, 2011.

J. M. Stein, R. Smeets, S. Reichert et al., “The role of the composite interleukin-1 genotype in the association between periodontitis and acute myocardial infarction,” Journal of Periodontology, vol. 80, no. 7, pp. 1095–1102, 2009.

L. S. Geiss, W. H. Herman, M. G. Goldschmid et al., “Surveillance for diabetes mellitus—United States, 1980–1989,” Morbidity and Mortality Weekly Report, vol. 42, no. 2, pp. 1–20, 1993.

T. Wu, M. Trevisan, R. J. Genco, J. P. Dorn, K. L. Falkner, and C. T. Sempos, “Periodontal disease and risk of cerebrovascular disease: the First National Health and Nutrition Examination Survey and its follow-up study,” Archives of Internal Medicine, vol. 160, no. 18, pp. 2749–2755, 2000.

R. I. Garcia, “No association between ischemic heart disease and periodontitis in women,” Evidence-Based Dentistry, vol. 11, no. 1, pp. 20–21, 2010.

M. Trevisan and J.Dorn, “The relationship between periodontal disease (Pd) and cardiovascular disease (Cvd),” Mediterranean Journal of Hematology and Infectious Diseases, vol. 2, no. 3, Article ID e2010030, 2010.

Chen, D. Y., Lin, C. H., Chen, Y. M., & Chen, H. H. (2016). Risk of atrial fibrillation or flutter associated with periodontitis: A nationwide, population‐based cohort study. PLoS ONE, 11, e0165601.

Kozarov, E. V., Dorn, B. R., Shelburne, C. E., Dunn, W. A. Jr, & Progulske‐ Fox, A. (2005). Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, e17–18.

Schenkein, H. A., & Loos, B. G. (2013). Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. Journal of Clinical Periodontology, 40(Suppl 14), S51–69.

de Oliveira, C., Watt, R., & Hamer, M. (2010). Toothbrushing, inflammation, and risk of cardiovascular disease: Results from Scottish Health Survey. British Medical Journal, 340, c2451.

Lockhart PB, Bolger AF, Papapanou PN, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation. 2012;125(20):2520–2544.

Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol. 2003;8(1):38–53.

Chen ZY, Chiang CH, Huang CC, et al. The association of tooth scaling and decreased cardiovascular disease: a nationwide population-based study. Am J Med. 2012;125(6):568–575

Lee YL, Hu HY, Huang N, Hwang DK, Chou P, Chu D. Dental pro¬phylaxis and periodontal treatment are protective factors to ischemic stroke. Stroke. 2013;44(4):1026–1030.